Shaodong Guo

Shaodong Guo

Auto-generated profile, based on publicly available information

Shaodong Guo

Centre for Bioinnovation, University of the Sunshine Coast, Sippy Downs, QLD, 4556, Australia; School of Science, Technology and Engineering, University of the Sunshine Coast, Sippy Downs, QLD, 4556, Australia

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

11 January 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
YWYue Wu
Yue Wu
ZCZhenling Cui
Zhenling Cui
YHYen-Hua Huang
Yen-Hua Huang
SVSimon J. de Veer
Simon J. de Veer
AAAndrey V. Aralov
Andrey V. Aralov
SMSergey Mureev
Sergey Mureev
Advances in peptide and protein therapeutics increased the need for rapid and cost-effective polypeptide prototyping. While in vitro translation systems are well suited for fast and multiplexed polypeptide prototyping, they suffer from misfolding, aggregation and disulfide-bond scrambling of the translated products. Here we propose that efficient folding of in vitro produced disulfide-rich peptides and proteins can be achieved if performed in an aggregation-free and thermodynamically controlled folding environment. To this end, we modify an E. coli-based in vitro translation system to allow co-translational capture of translated products by affinity matrix. This process reduces protein aggregation and enables productive oxidative folding and recycling of misfolded states under thermodynamic control. In this study we show that the developed approach is likely to be generally applicable for prototyping of a wide variety of disulfide-constrained peptides, macrocyclic peptides with non-native bonds and antibody fragments in amounts sufficient for interaction analysis and biological activity assessment.

25 November 2019 in ACS Pharmacology & Translational Science
Verified
Journal Article
Open access
CYChow Chun Yuen
Chow Chun Yuen
YCYanni K.-Y. Chin
Yanni K.-Y. Chin
AWAndrew A. Walker
Andrew A. Walker
SGShaodong Guo
Shaodong Guo
LBLinda V. Blomster
Linda V. Blomster
Glenn KingGlenn King
Glenn King
Voltage-gated sodium (NaV) channels play a fundamental role in normal neurological function, especially via the initiation and propagation of action potentials. The NaV1.1 subtype is found in inhibitory interneurons of the brain and it is essential for maintaining a balance between excitation and inhibition in neuronal networks. Heterozygous loss-of-function mutations of SCN1A, the gene encoding NaV1.1, underlie Dravet syndrome (DS), a severe pediatric epilepsy. We recently demonstrated that selective inhibition of NaV1.1 inactivation prevents seizures and premature death in a mouse model of DS. Thus, selective modulators of NaV1.1 might be useful therapeutics for treatment of DS as they target the underlying molecular deficit. Numerous scorpion-venom peptides have been shown to modulate the activity of NaV channels, but little is known about their activity at NaV1.1. Here we report the isolation, sequence, three-dimensional structure, recombinant production, and functional characterization of two peptidic modulators of NaV1.1 from venom of the buthid scorpion Hottentotta jayakari. These peptides, Hj1a and Hj2a, are potent agonists of NaV1.1 (EC50 of 17 and 32 nM, respectively), and they present dual α/β activity by modifying both the activation and inactivation properties of the channel. NMR studies of rHj1a indicate that it adopts a cystine-stabilized αβ fold similar to known scorpion toxins. Although Hj1a and Hj2a have only limited selectivity for NaV1.1, their unusual dual mode of action provides an alternative approach to the development of selective NaV1.1 modulators for the treatment of DS.

30 June 2020 in Biomedicines
Verified
Journal Article
Open access
PDF file
SNSamantha Nixon
Samantha Nixon
ZDZoltan Dekan
Zoltan Dekan
Samuel RobinsonSamuel Robinson
Samuel Robinson
SGShaodong Guo
Shaodong Guo
Irina VetterIrina Vetter
Irina Vetter
Volker HerzigVolker Herzig
Volker Herzig
Ant venoms have recently attracted increased attention due to their chemical complexity, novel molecular frameworks, and diverse biological activities. The heterodimeric peptide ∆-myrtoxin-Mp1a (Mp1a) from the venom of the Australian jack jumper ant, Myrmecia pilosula, exhibits antimicrobial, membrane-disrupting, and pain-inducing activities. In the present study, we examined the activity of Mp1a and a panel of synthetic analogues against the gastrointestinal parasitic nematode Haemonchus contortus, the fruit fly Drosophila melanogaster, and for their ability to stimulate pain-sensing neurons. Mp1a was found to be both insecticidal and anthelmintic, and it robustly activated mammalian sensory neurons at concentrations similar to those reported to elicit antimicrobial and cytotoxic activity. The native antiparallel Mp1a heterodimer was more potent than heterodimers with alternative disulfide connectivity, as well as monomeric analogues. We conclude that the membrane-disrupting effects of Mp1a confer broad-spectrum biological activities that facilitate both predation and defense for the ant. Our structure–activity data also provide a foundation for the rational engineering of analogues with selectivity for particular cell types.

15 October 2024 in Toxicon
Verified
Journal Article
Open access
YWYachen Wang
Yachen Wang
SGShaodong Guo
Shaodong Guo
Tomer VenturaTomer Ventura
Tomer Ventura
Volker HerzigVolker Herzig
Volker Herzig
Insecticides are vital for safeguarding agricultural crops against pests, albeit many lack selectivity towards pest species and are poorly bio-degradable. This leads to targeting of beneficial organisms like pollinators and widespread environmental contamination of soil and water. Exposure to insecticides such as neonicotinoids causes insect paralysis and mortality at higher doses, while sublethal doses can disrupt other functions that are crucial for survival such as learning and memory performance. Potent and selective arachnid venom peptides affecting a variety of molecular targets are being explored as bioinsecticide candidates. However, their effect on insect learning is poorly understood. We therefore established a sucrose-induced conditioned place preference (CPP) assay using Drosophila melanogaster fruit flies to provide a means of evaluating how various classes of insecticidal compounds interact with insect memory to assess their broader ecological consequences. Our results confirmed the adverse effect of a sublethal dose of the neonicotinoid insecticide imidacloprid (20 pg/fly) on fly CPP formation upon daily injection during the conditioning phase. However, imidacloprid did not affect CPP retrieval when applied after the conditioning phase. Sublethal doses of the two insecticidal spider venom peptides mu-DGTX-Dc1a (Dc1a; 70 pg/fly) and U1-AGTX-Ta1a (Ta1a; 125 pg/fly) had no effect on either CPP formation or retrieval, underlining their potential as novel and safe bioinsecticide candidates.

20 November 2025 in Toxicon
Verified
Journal Article
Open access
Volker HerzigVolker Herzig
Volker Herzig
YWYachen Wang
Yachen Wang
SGShaodong Guo
Shaodong Guo
Glenn KingGlenn King
Glenn King
Lepidopterans are the most economically significant crop pests. They are mainly controlled with chemical insecticides that often suffer from insect resistance and adverse effects on the environment and human health. Insect-specific spider-venom peptides are considered safer, eco-friendly alternatives to chemical insecticides, and two insecticidal spider-venom derived peptides have already been commercialised by Vestaron Corporation, while more candidates are being progressed in global discovery pipelines. This study focusses on two insecticidal spider-venom peptides-Dc1a and Ta1a- and assesses their suitability in targeting five species of lepidopteran pests by injection and oral application, using Vestaron's commercial ω/κ-Hv1a as a reference. In addition, the potential of bacterial Bt Cry toxins in providing synergistic insecticidal activities with these spider-venom peptides is evaluated. We found that when applied by injection, all peptides caused paralysis and mortality against all tested lepidopteran species within a narrow dose range. In contrast, the differences in insecticidal activity were more pronounced when orally applied. Helicoverpa consistently was the genus most susceptible to the spider-venom peptides, independent of the route of application, which we presume being related to its particular food preferences. Furthermore, we found synergistic activities for co-application of each of the spider-venom peptides with sublethal amounts of Bt Cry toxins in H. armigera. Overall, our results indicate that Dc1a and Ta1a are suitable bioinsecticide candidates for targeting certain lepidopteran pests, with co-application of Bt Cry toxins considered a viable strategy for increasing their efficacy as foliar sprays.